From: TGM3, a candidate tumor suppressor gene, contributes to human head and neck cancer
Characteristics | HR | 95% CI | P |
---|---|---|---|
Univariate analysis | Â | Â | Â |
Overall survival | Â | Â | Â |
Age (<60 y vs ≥ 60 y) | 0.633 | 0.282 to 1.419 | 0.267 |
Gender (male vs female) | 1.713 | 0.763 to 3.844 | 0.192 |
Smoking history (smoker vs nonsmoker) | 0.643 | 0.295 to 1.401 | 0.267 |
Alcohol history (drinker vs nondrinker) | 0.718 | 0.302 to 1.709 | 0.454 |
Tumor grade | 2.096 | 1.283 to 3.425 | 0.003 |
TNM stage | 1.784 | 1.181 to 2.696 | 0.006 |
Lymph node metastasis (pN0 vs pN1 to pN2) | 2.514 | 1.153 to 5.481 | 0.020 |
TGM3 expression (high vs low) | 0.191 | 0.072 to 0.506 | 0.001 |
Disease site | 1.023 | 0.637 to 1.660 | 0.926 |
Multivariate analysis | Â | Â | Â |
Overall survival | Â | Â | Â |
Tumor grade | 1.737 | 1.042 to 2.895 | 0.034 |
TNM stage | 1.325 | 0.806 to 2.177 | 0.267 |
Lymph node metastasis (pN0 vs pN1 to pN2) | 1.515 | 0.586 to 3.909 | 0.391 |
TGM3 expression (high vs low) | 0.286 | 0.103 to 0.796 | 0.016 |